ChristopherSeverynMDPhD(He/Him)
Pediatrics • Palo Alto, CAPediatric Hematology/Oncology
Instructor of Pediatrics (Stem Cell Transplant & Regenerative Medicine)
Dr. Severyn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Welch Road, Suite 301
Pediatric Hematology / Oncology
Palo Alto, CA 94304Phone+1 650-723-5535
Summary
- I am a physician-scientist with extensive research experience in molecular biology and clinical training in pediatric hematology-oncology, and board certification in General Pediatrics. My current clinical and translational research focuses on understanding how the microbes in our bodies interact with our immune system, with a particular focus on the hematopoietic system.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2017 - 2020
Duke University HospitalResidency, Pediatrics, 2013 - 2016
Oregon Health and Science University School of MedicineClass of 2013
Oregon Health & Science UniversityPhD, Biochemistry & Molecular Biology, 2005 - 2010- University of California, BerkeleyBA, Molecular and Cell Biology (Immunology), 1998 - 2002
Certifications & Licensure
CA State Medical License 2016 - 2026
NC State Medical License 2015 - 2017- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Stanford Maternal & Children’s Health Research Institute (M-CHRI) Clinical Trainee Award Pete and Arline Harmen Fellow through the Alan Krensky, MD, Endowed Clinical Fellowship Fund and the Lucile Packard Children’s Hospital Clinical Fellowship Fund
- Institute for Pediatric Research Duke University Medical Center
- Duke Pediatrics Residency, Medical Student Teaching Award Duke University Medical Center
- Join now to see all
Clinical Trials
- Gut Decontamination In Pediatric Allogeneic Hematopoietic Start of enrollment: 2016 Mar 01
- Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma Start of enrollment: 2021 Feb 24
Publications & Presentations
PubMed
- 33 citationsGut Colonization Preceding Mucosal Barrier Injury Bloodstream Infection in Pediatric Hematopoietic Stem Cell Transplantation RecipientsMatthew S. Kelly, Doyle V. Ward, Christopher J. Severyn, Mehreen Arshad, Sarah M Heston
Biology of Blood and Marrow Transplantation. 2019-07-18 - 16 citationsMicrobiota modification in hematology: still at the bench or ready for the bedside?Christopher J Severyn, Ryan Brewster, Tessa M Andermann
Blood Advances. 2019-11-12 - 15 citationsMicrobiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation.Christopher J Severyn, Benjamin A Siranosian, Sandra Tian-Jiao Kong, Angel Moreno, Michelle M Li
JCI Insight. 2022-04-08
Other
- Regulation & Evolutionary Origins of RGMc/Hemojuvelin expression: an Muscle-enriched gene involved in Iron MetabolismSeveryn, C.J., Dissertation
http://digitalcommons.ohsu.edu/etd/503/
Oregon Health & Science Univ. digital library - 7/2010
Professional Memberships
- Member
- Member
Industry Relationships
- Medical Director, Clinical Development, Allogene Therapeutics2023 - Present
External Links
- GitHubhttps://github.com/chrissev
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
